Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers. It also owns and operates retail cannabis store in Winnipeg, Manitoba, as well as cannabis superstore in Brandon, Manitoba. The company operates its retail stores under the Delta 9 Cannabis Store brand name. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone855-245-1259
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$12.87 million
Profitability
Miscellaneous
Employees79
Next Earnings DateN/A
OptionableOptionable
Delta 9 Cannabis (CVE:NINE) Frequently Asked Questions
What is Delta 9 Cannabis' stock symbol?
Delta 9 Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NINE."
What price target have analysts set for NINE?
0 equities research analysts have issued twelve-month price targets for Delta 9 Cannabis' stock. Their forecasts range from C$2.20 to C$2.20. On average, they expect Delta 9 Cannabis' share price to reach C$2.20 in the next twelve months. This suggests a possible upside of 88.0% from the stock's current price. View Analyst Price Targets for Delta 9 Cannabis.
Has Delta 9 Cannabis been receiving favorable news coverage?
Headlines about NINE stock have been trending positive this week, according to InfoTrie. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Delta 9 Cannabis earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the next few days. View News Stories for Delta 9 Cannabis.
Who are some of Delta 9 Cannabis' key competitors?
Some companies that are related to Delta 9 Cannabis include Benchmark (BMK), ICC Labs (ICC), Depomed (ASRT), WeedMD (WMD), Althea Group (AGH), Shield Therapeutics (STX), Harvest One Cannabis (HVT), Auscann Group (AC8), Eve & Co Inc (EVE), Biosyent (RX), Probiotec (PBP), Invion (IVX), Science in Sport (SIS), MGC Pharmaceuticals (MXC) and InMed Pharmaceuticals (IN).
What other stocks do shareholders of Delta 9 Cannabis own?
Who are Delta 9 Cannabis' key executives?
Delta 9 Cannabis' management team includes the folowing people:
- Mr. John William Arbuthnot III, Co-Founder, Pres & Chairman (Age 65)
- Mr. John William Arbuthnot IV, Co-Founder, CEO & Director (Age 29)
- Mr. Jim Lawson, Interim CFO & Controller
- Mr. Matthew Sodomsky, Chief Technology Officer
How do I buy shares of Delta 9 Cannabis?
Shares of NINE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Delta 9 Cannabis' stock price today?
One share of NINE stock can currently be purchased for approximately C$1.17.
How big of a company is Delta 9 Cannabis?
What is Delta 9 Cannabis' official website?
How can I contact Delta 9 Cannabis?
The company can be reached via phone at 855-245-1259.
MarketBeat Community Rating for Delta 9 Cannabis (CVE NINE)
MarketBeat's community ratings are surveys of what our community members think about Delta 9 Cannabis and other stocks. Vote "Outperform" if you believe NINE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NINE will underperform the S&P 500 over the long term. You may vote once every thirty days.
